Surgalign Holdings Analysis
| SRGADelisted Stock | USD 0.04 0 12.54% |
Surgalign Holdings is overvalued with Real Value of 0.0333 and Hype Value of 0.04. The main objective of Surgalign Holdings delisted stock analysis is to determine its intrinsic value, which is an estimate of what Surgalign Holdings is worth, separate from its market price. There are two main types of Surgalign Holdings' stock analysis: fundamental analysis and technical analysis.
The Surgalign Holdings stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Surgalign Holdings' ongoing operational relationships across important fundamental and technical indicators.
Surgalign |
Surgalign Stock Analysis Notes
About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.79. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgalign Holdings recorded a loss per share of 8.12. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 17th of May 2022. Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Surgalign Hldg operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 231 people. To find out more about Surgalign Holdings contact Terry Rich at 224 303 4651 or learn more at https://www.surgalign.com.Surgalign Holdings Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Surgalign Holdings' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Surgalign Holdings or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Surgalign Holdings is not yet fully synchronised with the market data | |
| Surgalign Holdings has some characteristics of a very speculative penny stock | |
| Surgalign Holdings has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 81.98 M. Net Loss for the year was (54.6 M) with profit before overhead, payroll, taxes, and interest of 40.29 M. | |
| Surgalign Holdings currently holds about 29.34 M in cash with (52.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.35, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
Surgalign Holdings Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Surgalign Holdings previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of August 2023 Upcoming Quarterly Report | View | |
| 1st of November 2023 Next Financial Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Surgalign Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.68 M.Surgalign Profitablity
The company has Profit Margin (PM) of (0.65) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.68) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.68.Surgalign Holdings Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgalign Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgalign Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgalign Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Enrico Sangiorgio over a year ago Payment of 209 shares by Enrico Sangiorgio of Surgalign Holdings subject to Rule 16b-3 | ||
Terry Rich over a year ago Payment of 190 shares by Terry Rich of Surgalign Holdings subject to Rule 16b-3 | ||
Terry Rich over a year ago Payment of 540 shares by Terry Rich of Surgalign Holdings subject to Rule 16b-3 |
Surgalign Holdings Outstanding Bonds
Surgalign Holdings issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Surgalign Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Surgalign bonds can be classified according to their maturity, which is the date when Surgalign Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Surgalign Holdings Predictive Daily Indicators
Surgalign Holdings intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Surgalign Holdings stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Surgalign Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Surgalign Holdings prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Surgalign shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Surgalign Holdings. By using and applying Surgalign Stock analysis, traders can create a robust methodology for identifying Surgalign entry and exit points for their positions.
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Surgalign Hldg operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 231 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Surgalign Holdings to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Surgalign Stock
If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |